Orforglipron is a new oral GLP-1 medication being developed to support weight loss and type 2 diabetes treatment. Unlike injectable GLP-1 medications such as Wegovy and Mounjaro, orforglipron is taken as a once-daily tablet. It works by helping regulate appetite, reduce cravings and lower calorie intake, supporting sustainable weight loss over time.
Early clinical trial results have shown promising weight loss outcomes, making orforglipron one of the most anticipated upcoming alternatives to injectable weight loss medication.